The American Physiological Society Press Release

press release logo

APS Contact: APS Communications Office

Email: communications@the-aps.org

Phone: 301.634.7209

Twitter: @APSPhysiology


Stem Cell Therapy Drug May Protect against Smoke-related COPD Symptoms

Stem cell mobilization protects lung function in mouse study

Rockville, Md. (July 5, 2018)—A drug used in stem cell therapy to treat certain cancers may also protect against cigarette smoke-induced lung injury. The study, published ahead of print in the American Journal of Physiology—Lung Cellular and Molecular Physiology, was chosen as an APSselect article for July.

Plerixafor is a medication that stimulates the immune system to release more of a type of stem cell (hematopoietic progenitor cells, or HPCs) from the bone marrow into the bloodstream. The drug is used to treat some types of cancer that originate in the blood cells, including multiple myeloma and non-Hodgkin lymphoma. Stem cells have the potential to develop into many different kinds of cells in the body and are involved in tissue repair. Previous research has shown that lower numbers of HPCs in the bloodstream correspond to increased severity of emphysema, a form of chronic obstructive pulmonary disease (COPD). COPD is a progressive lung disease that makes breathing difficult.

Studies suggest the reduced number of circulating HPCs prevents the lungs from being able to repair smoke-related damage. Based on this theory, researchers explored the effect of plerixafor on stem cell circulation—and subsequent lung function—in mice. One group of animals was exposed to cigarette smoke five days a week for 22 weeks and received regular injections of plerixafor (“treated”), and another group was exposed to smoke but did not receive treatment (“exposed”).

The researchers collected stem cells from all groups of mice and found a drop in the number of cells in the exposed group early in the trial period, which is consistent with findings that even brief cigarette smoke exposures reduce HPC populations in the bone marrow, according to the research team. Conversely, there was no detectable depletion of HPCs in the treated group, and, in fact, numbers increased after two weeks of treatment. Lung fluid samples from the treated group showed no significant changes in the number of white blood cells or inflammation as compared to a control group. Increases in these factors typically indicate illness or injury.

The protective effects of plerixafor on smoke-induced lung injury “raise the possibility that [bone marrow] mobilization increases the availability of HPC for lung cell maintenance and repair,” the researchers wrote. “Our report supports the usefulness of this FDA-approved drug as a potential treatment for emphysema.”

Read the full article, “AMD3100 ameliorates cigarette smoke-induced emphysema-like manifestations in mice,” published ahead of print in the American Journal of Physiology—Lung Cellular and Molecular Physiology. It is highlighted as one of this month’s “best of the best” as part of the American Physiological Society’s APSselect program. Read all of this month’s selected research articles.

NOTE TO JOURNALISTS: To schedule an interview with a member of the research team, please contact the APS Communications Office or 301-634-7209. Find more research highlights in the APS Press Room.

Physiology is the study of how molecules, cells, tissues and organs function in health and disease. Established in 1887, the American Physiological Society (APS) was the first U.S. society in the biomedical sciences field. The Society represents more than 10,500 members and publishes 15 peer-reviewed journals with a worldwide readership.

 


RelatedItems

New Research Shows Why Statins Should Be Viewed as a Double-Edged Sword

Released August 13, 2015 - Statins have significant cardiovascular benefits, but also serious side effects. A new study finds that statin use impairs stem cell function, which helps in slowing atherosclerosis but hinders other body processes. Because of these effects, the study supports weighing individual risk when considering statins as a preventive measure.

A New Use for Statins: Asthma

Released May 26, 2015 - Researchers report that statins inhaled as a spray can treat symptoms of asthma. The findings support that statins should be explored as a new class of inhaler therapy for asthma.

E-Cigarette Vapor—Even when Nicotine-Free—Found to Damage Lung Cells

Released May 26, 2015 - With the use of e-cigarettes on the rise, especially among young people, research to uncover the health effects of e-cigs is becoming increasingly important. In a new study published ahead of print in AJP-Lung, researchers find that e-cig solution and vapors—even those that are nicotine-free—damage lung health.

Cigarette Smoke Exposure Increases Scar Tissue in the Kidney and Heart, Study Finds

Released December 1, 2016 - Smoking may lead to fibrosis in the heart and kidneys and can worsen existing kidney disease, according to a new study published in Physiological Genomics. The research team suggests that exposure to cigarette smoke negatively affects genetic messaging that controls tissue scarring.

From: 
Email:  
To: 
Email:  
Subject: 
Message:

~/Custom.Templates/PressRelease.aspx